{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:27:09Z","timestamp":1792808829077,"version":"4.5.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBTHRDPMU\/JRF\/BET-21\/I\/2021-22\/369"],"award-info":[{"award-number":["DBTHRDPMU\/JRF\/BET-21\/I\/2021-22\/369"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/2\/109\/2022-NCD-III"],"award-info":[{"award-number":["3\/2\/2\/109\/2022-NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/20\/2022-BIO\/BMS"],"award-info":[{"award-number":["45\/20\/2022-BIO\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/10\/FR\/23\/2021-RBMCH"],"award-info":[{"award-number":["5\/10\/FR\/23\/2021-RBMCH"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"DOI":"10.1007\/s11154-025-09975-4","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T09:35:31Z","timestamp":1749461731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pathophysiological insights into asprosin: an emerging adipokine in reproductive health"],"prefix":"10.1007","author":[{"given":"Sana","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Syeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashankita","family":"Raghuvanshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"10","key":"9975_CR1","doi-asserted-by":"publisher","first-page":"e12590","DOI":"10.1111\/jne.12590","volume":"30","author":"A Acevedo-Rodriguez","year":"2018","unstructured":"Acevedo-Rodriguez A, Kauffman AS, Cherrington BD, Borges CS, Roepke TA, Laconi M. Emerging insights into hypothalamic-pituitary-gonadal axis regulation and interaction with stress signalling. J Neuroendocrinol. 2018;30(10):e12590. https:\/\/doi.org\/10.1111\/jne.12590.","journal-title":"J. Neuroendocrinol."},{"issue":"5","key":"9975_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/10253890.2017.1369523","volume":"20","author":"MG Oyola","year":"2017","unstructured":"Oyola MG, Handa RJ. Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: sex differences in regulation of stress responsivity. Stress. 2017;20(5):476\u201394. https:\/\/doi.org\/10.1080\/10253890.2017.1369523.","journal-title":"Stress"},{"issue":"11","key":"9975_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1042\/CS20220146","volume":"137","author":"K Koysombat","year":"2023","unstructured":"Koysombat K, Dhillo WS, Abbara A. Assessing hypothalamic pituitary gonadal function in reproductive disorders. Clin Sci (Lond). 2023;137(11):863\u201379. https:\/\/doi.org\/10.1042\/CS20220146.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"9975_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmv016","volume":"21","author":"MC Inhorn","year":"2015","unstructured":"Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2015;21(4):411\u201326. https:\/\/doi.org\/10.1093\/humupd\/dmv016.","journal-title":"Hum Reprod Update"},{"issue":"7","key":"9975_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/humrep\/deh303","volume":"19","author":"JDF Habbema","year":"2004","unstructured":"Habbema JDF, Collins J, Leridon H, Evers JLH, Lunenfeld B, te Velde ER. Towards less confusing terminology in reproductive medicine: a proposal. Hum Reprod. 2004;19(7):1497\u2013501. https:\/\/doi.org\/10.1093\/humrep\/deh303.","journal-title":"Hum Reprod"},{"issue":"Suppl","key":"9975_CR6","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.4103\/ijmr.IJMR_636_18","volume":"148","author":"RS Sharma","year":"2018","unstructured":"Sharma RS, Saxena R, Singh R. Infertility & assisted reproduction: A historical & modern scientific perspective. Indian J Med Res. 2018;148(Suppl):S10\u20134. https:\/\/doi.org\/10.4103\/ijmr.IJMR_636_18.","journal-title":"Indian J Med Res"},{"issue":"1","key":"9975_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12958-018-0336-z","volume":"16","author":"E Silvestris","year":"2018","unstructured":"Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1):22. https:\/\/doi.org\/10.1186\/s12958-018-0336-z.","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"4","key":"9975_CR8","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.fertnstert.2017.01.017","volume":"107","author":"DE Broughton","year":"2017","unstructured":"Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity\u2019s impact. Fertil Steril. 2017;107(4):840\u20137. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.01.017.","journal-title":"Fertil Steril"},{"issue":"4","key":"9975_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.fertnstert.2017.02.115","volume":"107","author":"JR Craig","year":"2017","unstructured":"Craig JR, Jenkins TG, Carrell DT, Hotaling JM. Obesity, male infertility, and the sperm epigenome. Fertil Steril. 2017;107(4):848\u201359. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.02.115.","journal-title":"Fertil Steril"},{"key":"9975_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","volume":"92","author":"CJ Glueck","year":"2019","unstructured":"Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism. 2019;92:108\u201320. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.002.","journal-title":"Metabolism"},{"issue":"3","key":"9975_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12020-021-02884-x","volume":"74","author":"N Mili","year":"2021","unstructured":"Mili N, Paschou SA, Goulis DG, Dimopoulos M-A, Lambrinoudaki I, Psaltopoulou T. Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations. Endocrine. 2021;74(3):478\u201397. https:\/\/doi.org\/10.1007\/s12020-021-02884-x.","journal-title":"Endocrine"},{"issue":"12","key":"9975_CR12","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S2213-8587(16)30278-9","volume":"4","author":"RCW Ma","year":"2016","unstructured":"Ma RCW, Schmidt MI, Tam WH, McIntyre HD, Catalano PM. \u201cClinical management of pregnancy in the obese mother: before conception, during pregnancy, and post partum\u201d, lancet. Diabetes Endocrinol. 2016;4(12):1037\u201349. https:\/\/doi.org\/10.1016\/S2213-8587(16)30278-9.","journal-title":"Diabetes Endocrinol."},{"issue":"11","key":"9975_CR13","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.115.306885","volume":"118","author":"JJ Fuster","year":"2016","unstructured":"Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res. 2016;118(11):1786\u2013807. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306885.","journal-title":"Circ Res"},{"issue":"7","key":"9975_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","volume":"36","author":"M Fasshauer","year":"2015","unstructured":"Fasshauer M, Bl\u00fcher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36(7):461\u201370. https:\/\/doi.org\/10.1016\/j.tips.2015.04.014.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"9975_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/OGX.0b013e318217b0a4","volume":"66","author":"C Tersigni","year":"2011","unstructured":"Tersigni C, Di Nicuolo F, D\u2019Ippolito S, Veglia M, Castellucci M, Di Simone N. Adipokines: new emerging roles in fertility and reproduction. Obstet Gynecol Surv. 2011;66(1):47\u201363. https:\/\/doi.org\/10.1097\/OGX.0b013e318217b0a4.","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"9975_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.ijo.0803719","volume":"32","author":"DB Campos","year":"2008","unstructured":"Campos DB, Palin M-F, Bordignon V, Murphy BD. The \u2018beneficial\u2019 adipokines in reproduction and fertility. Int J Obes (Lond). 2008;32(2):223\u201331. https:\/\/doi.org\/10.1038\/sj.ijo.0803719.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"9975_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1515\/hmbci-2015-0034","volume":"24","author":"J Dupont","year":"2015","unstructured":"Dupont J, Pollet-Villard X, Reverchon M, Mellouk N, Levy R. Adipokines in human reproduction. Horm Mol Biol Clin Investig. 2015;24(1):11\u201324. https:\/\/doi.org\/10.1515\/hmbci-2015-0034.","journal-title":"Horm Mol Biol Clin Investig"},{"key":"9975_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/bs.acc.2024.04.006","volume":"121","author":"M Dawid","year":"2024","unstructured":"Dawid M, et al. Adipokines in pregnancy. Adv Clin Chem. 2024;121:172\u2013269. https:\/\/doi.org\/10.1016\/bs.acc.2024.04.006.","journal-title":"Adv Clin Chem"},{"key":"9975_CR19","doi-asserted-by":"publisher","first-page":"105852","DOI":"10.1016\/j.jsbmb.2021.105852","volume":"209","author":"S Nikanfar","year":"2021","unstructured":"Nikanfar S, et al. Role of adipokines in the ovarian function: Oogenesis and steroidogenesis. J Steroid Biochem Mol Biol. 2021;209:105852. https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105852.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"9975_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","volume":"165","author":"C Romere","year":"2016","unstructured":"Romere C, et al. Asprosin, a Fasting-Induced Glucogenic Protein Hormone. Cell. 2016;165(3):566\u201379. https:\/\/doi.org\/10.1016\/j.cell.2016.02.063.","journal-title":"Cell"},{"key":"9975_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fendo.2020.00064","volume":"11","author":"M Yuan","year":"2020","unstructured":"Yuan M, Li W, Zhu Y, Yu B, Wu J. Asprosin: A Novel Player in Metabolic Diseases. Front Endocrinol (Lausanne). 2020;11:64. https:\/\/doi.org\/10.3389\/fendo.2020.00064.","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"9975_CR22","doi-asserted-by":"publisher","first-page":"1101091","DOI":"10.3389\/fendo.2022.1101091","volume":"13","author":"M Farrag","year":"2022","unstructured":"Farrag M, et al. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects. Front Endocrinol (Lausanne). 2022;13:1101091. https:\/\/doi.org\/10.3389\/fendo.2022.1101091.","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"9975_CR23","doi-asserted-by":"publisher","first-page":"101397","DOI":"10.1016\/j.tice.2020.101397","volume":"66","author":"N Kocaman","year":"2020","unstructured":"Kocaman N, Kulo\u011flu T. Expression of asprosin in rat hepatic, renal, heart, gastric, testicular and brain tissues and its changes in a streptozotocin-induced diabetes mellitus model. Tissue Cell. 2020;66:101397. https:\/\/doi.org\/10.1016\/j.tice.2020.101397.","journal-title":"Tissue Cell"},{"key":"9975_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.mce.2019.03.001","volume":"486","author":"T Lee","year":"2019","unstructured":"Lee T, Yun S, Jeong JH, Jung TW. Asprosin impairs insulin secretion in response to glucose and viability through TLR4\/JNK-mediated inflammation. Mol Cell Endocrinol. 2019;486:96\u2013104. https:\/\/doi.org\/10.1016\/j.mce.2019.03.001.","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"9975_CR25","doi-asserted-by":"publisher","first-page":"20888","DOI":"10.1002\/jcp.28694","volume":"234","author":"TW Jung","year":"2019","unstructured":"Jung TW, et al. Asprosin attenuates insulin signaling pathway through PKC\u03b4-activated ER stress and inflammation in skeletal muscle. J Cell Physiol. 2019;234(11):20888\u201399. https:\/\/doi.org\/10.1002\/jcp.28694.","journal-title":"J Cell Physiol"},{"issue":"4","key":"9975_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/10520295.2023.2176546","volume":"98","author":"A Yavuz","year":"2023","unstructured":"Yavuz A, et al. Betatrophin, elabela, asprosin, glucagon and subfatin peptides in breast tissue, blood and milk in gestational diabetes. Biotech Histochem Off Publ Biol Stain Comm. 2023;98(4):243\u201354. https:\/\/doi.org\/10.1080\/10520295.2023.2176546.","journal-title":"Biotech. Histochem. Off. Publ. Biol. Stain Comm"},{"issue":"1","key":"9975_CR27","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s41598-022-05060-x","volume":"12","author":"YAT Morcos","year":"2022","unstructured":"Morcos YAT, et al. Sensitive asprosin detection in clinical samples reveals serum\/saliva correlation and indicates cartilage as source for serum asprosin. Sci Rep. 2022;12(1):1340. https:\/\/doi.org\/10.1038\/s41598-022-05060-x.","journal-title":"Sci. Rep."},{"key":"9975_CR28","doi-asserted-by":"publisher","first-page":"2521096","DOI":"10.1155\/2019\/2521096","volume":"2019","author":"K Ugur","year":"2019","unstructured":"Ugur K, Aydin S. Saliva and Blood Asprosin Hormone Concentration Associated with Obesity. Int J Endocrinol. 2019;2019:2521096. https:\/\/doi.org\/10.1155\/2019\/2521096.","journal-title":"Int J Endocrinol"},{"issue":"1","key":"9975_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5603\/EP.a2020.0059","volume":"72","author":"N Gozel","year":"2021","unstructured":"Gozel N, Kilinc F. Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin. Endokrynol Pol. 2021;72(1):37\u201343. https:\/\/doi.org\/10.5603\/EP.a2020.0059.","journal-title":"Endokrynol Pol"},{"key":"9975_CR30","doi-asserted-by":"publisher","unstructured":"A. I. Mazur-Bialy, (2021) \u201cAsprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature.,\u201d Nutrients, vol. 13, no. 2. https:\/\/doi.org\/10.3390\/nu13020620.","DOI":"10.3390\/nu13020620"},{"issue":"12","key":"9975_CR31","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/nm.4432","volume":"23","author":"C Duerrschmid","year":"2017","unstructured":"Duerrschmid C, et al. Asprosin is a centrally acting orexigenic hormone. Nat Med. 2017;23(12):1444\u201353. https:\/\/doi.org\/10.1038\/nm.4432.","journal-title":"Nat Med"},{"issue":"4","key":"9975_CR32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cmet.2022.02.012","volume":"34","author":"I Mishra","year":"2022","unstructured":"Mishra I, et al. Protein tyrosine phosphatase receptor \u03b4 serves as the orexigenic asprosin receptor. Cell Metab. 2022;34(4):549-563.e8. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.012.","journal-title":"Cell Metab"},{"issue":"4","key":"9975_CR33","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2019.02.004","volume":"29","author":"M von Herrath","year":"2019","unstructured":"von Herrath M, et al. Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes. Cell Metab. 2019;29(4):795\u2013802. https:\/\/doi.org\/10.1016\/j.cmet.2019.02.004.","journal-title":"Cell Metab"},{"key":"9975_CR34","doi-asserted-by":"publisher","first-page":"6622129","DOI":"10.1155\/2021\/6622129","volume":"2021","author":"T Hong","year":"2021","unstructured":"Hong T, et al. High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome. Int J Endocrinol. 2021;2021:6622129. https:\/\/doi.org\/10.1155\/2021\/6622129.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"9975_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cmet.2019.05.022","volume":"30","author":"E Li","year":"2019","unstructured":"Li E, et al. OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin. Cell Metab. 2019;30(2):319-328.e8. https:\/\/doi.org\/10.1016\/j.cmet.2019.05.022.","journal-title":"Cell Metab"},{"issue":"2","key":"9975_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/JOE-20-0503","volume":"249","author":"Y Miao","year":"2021","unstructured":"Miao Y, Qin H, Zhong Y, Huang K, Rao C. Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue. J Endocrinol. 2021;249(2):83\u201393. https:\/\/doi.org\/10.1530\/JOE-20-0503.","journal-title":"J Endocrinol"},{"issue":"7","key":"9975_CR37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41366-024-01495-6","volume":"48","author":"S Chen","year":"2024","unstructured":"Chen S, et al. Asprosin contributes to pathogenesis of obesity by adipocyte mitophagy induction to inhibit white adipose browning in mice. Int J Obes (Lond). 2024;48(7):913\u201322. https:\/\/doi.org\/10.1038\/s41366-024-01495-6.","journal-title":"Int J Obes (Lond)"},{"key":"9975_CR38","doi-asserted-by":"publisher","unstructured":"T. Yin et al., \u201cAngiogenesis-Browning Interplay Mediated by Asprosin-Knockout Contributes to Weight Loss in Mice with Obesity.,\u201d Int. J. Mol. Sci., vol. 23, no. 24, Dec. 2022. https:\/\/doi.org\/10.3390\/ijms232416166.","DOI":"10.3390\/ijms232416166"},{"issue":"1","key":"9975_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12902-024-01560-1","volume":"24","author":"J Cui","year":"2024","unstructured":"Cui J, Liu Y, Li M, Yin J, Yang J, Xu L. Association of serum asprosin with metabolic dysfunction-associated fatty liver disease in older adult type 2 diabetic patients: a cross-sectional study. BMC Endocr Disord. 2024;24(1):27. https:\/\/doi.org\/10.1186\/s12902-024-01560-1.","journal-title":"BMC Endocr. Disord."},{"key":"9975_CR40","doi-asserted-by":"publisher","first-page":"155184","DOI":"10.1016\/j.cyto.2020.155184","volume":"134","author":"F Ke","year":"2020","unstructured":"Ke F, et al. Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease. Cytokine. 2020;134:155184. https:\/\/doi.org\/10.1016\/j.cyto.2020.155184.","journal-title":"Cytokine"},{"issue":"1","key":"9975_CR41","doi-asserted-by":"publisher","first-page":"11170","DOI":"10.1038\/s41598-024-62124-w","volume":"14","author":"D Lv","year":"2024","unstructured":"Lv D, Wang Z, Meng C, Li Y, Ji S. A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examination. Sci Rep. 2024;14(1):11170. https:\/\/doi.org\/10.1038\/s41598-024-62124-w.","journal-title":"Sci. Rep."},{"issue":"4","key":"9975_CR42","doi-asserted-by":"publisher","first-page":"e22213","DOI":"10.1002\/ddr.22213","volume":"85","author":"C Wang","year":"2024","unstructured":"Wang C, et al. Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen species. Drug Dev Res. 2024;85(4):e22213. https:\/\/doi.org\/10.1002\/ddr.22213.","journal-title":"Drug Dev. Res."},{"issue":"1","key":"9975_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jcp.29835","volume":"236","author":"R Wang","year":"2021","unstructured":"Wang R, Hu W. Asprosin promotes \u03b2-cell apoptosis by inhibiting the autophagy of \u03b2-cell via AMPK-mTOR pathway. J Cell Physiol. 2021;236(1):215\u201321. https:\/\/doi.org\/10.1002\/jcp.29835.","journal-title":"J Cell Physiol"},{"issue":"1","key":"9975_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13098-022-00844-7","volume":"14","author":"HK Hussein","year":"2022","unstructured":"Hussein HK, et al. Association of cord blood asprosin concentration with atherogenic lipid profile and anthropometric indices. Diabetology & metabolic syndrome. 2022;14(1):74. https:\/\/doi.org\/10.1186\/s13098-022-00844-7.","journal-title":"Diabetology & metabolic syndrome"},{"key":"9975_CR45","doi-asserted-by":"publisher","first-page":"109737","DOI":"10.1016\/j.enzmictec.2020.109737","volume":"144","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhu Z, Zhai W, Bi Y, Yin Y, Zhang W. Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK. Enzyme Microb Technol. 2021;144:109737. https:\/\/doi.org\/10.1016\/j.enzmictec.2020.109737.","journal-title":"Enzyme Microb Technol"},{"issue":"1","key":"9975_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12944-021-01514-9","volume":"20","author":"N Moradi","year":"2021","unstructured":"Moradi N, Fouani FZ, Vatannejad A, Bakhti Arani A, Shahrzad S, Fadaei R. Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study. Lipids Health Dis. 2021;20(1):88. https:\/\/doi.org\/10.1186\/s12944-021-01514-9.","journal-title":"Lipids Health Dis."},{"issue":"1","key":"9975_CR47","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s12872-023-03668-z","volume":"23","author":"G Wang","year":"2023","unstructured":"Wang G, et al. Association of serum Asprosin concentrations with heart failure. BMC Cardiovasc Disord. 2023;23(1):617. https:\/\/doi.org\/10.1186\/s12872-023-03668-z.","journal-title":"BMC Cardiovasc. Disord"},{"issue":"1","key":"9975_CR48","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12872-020-01680-1","volume":"20","author":"M-S Wen","year":"2020","unstructured":"Wen M-S, et al. The role of Asprosin in patients with dilated cardiomyopathy. BMC Cardiovasc Disord. 2020;20(1):402. https:\/\/doi.org\/10.1186\/s12872-020-01680-1.","journal-title":"BMC Cardiovasc. Disord."},{"key":"9975_CR49","doi-asserted-by":"publisher","first-page":"116554","DOI":"10.1016\/j.lfs.2019.116554","volume":"231","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, et al. Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1\/2-SOD2 pathway. Life Sci. 2019;231:116554. https:\/\/doi.org\/10.1016\/j.lfs.2019.116554.","journal-title":"Life Sci"},{"key":"9975_CR50","doi-asserted-by":"publisher","unstructured":"M. Yu et al., \u201cChemerin: A Functional Adipokine in Reproductive Health and Diseases.,\u201d Biomedicines, vol. 10, no. 8, Aug. 2022. https:\/\/doi.org\/10.3390\/biomedicines10081910.","DOI":"10.3390\/biomedicines10081910"},{"key":"9975_CR51","doi-asserted-by":"publisher","unstructured":"F. Yang, S. Zhao, P. Wang, and W. Xiang, \u201cHypothalamic neuroendocrine integration of reproduction and metabolism in mammals.,\u201d J. Endocrinol., vol. 258, no. 3, Sep. 2023. https:\/\/doi.org\/10.1530\/JOE-23-0079.","DOI":"10.1530\/JOE-23-0079"},{"key":"9975_CR52","doi-asserted-by":"publisher","first-page":"100963","DOI":"10.1016\/j.yfrne.2021.100963","volume":"64","author":"S Ogawa","year":"2022","unstructured":"Ogawa S, Parhar IS. Heterogeneity in GnRH and kisspeptin neurons and their significance in vertebrate reproductive biology. Front Neuroendocrinol. 2022;64:100963. https:\/\/doi.org\/10.1016\/j.yfrne.2021.100963.","journal-title":"Front Neuroendocrinol"},{"key":"9975_CR53","doi-asserted-by":"publisher","unstructured":"X.-L. Wang et al., \u201cAsprosin in the Paraventricular Nucleus Induces Sympathetic Activation and Pressor Responses via cAMP-Dependent ROS Production.,\u201d Int. J. Mol. Sci., vol. 23, no. 20, Oct. 2022. https:\/\/doi.org\/10.3390\/ijms232012595.","DOI":"10.3390\/ijms232012595"},{"issue":"4","key":"9975_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5483\/bmbrep.2015.48.4.272","volume":"48","author":"J-W Sohn","year":"2015","unstructured":"Sohn J-W. Network of hypothalamic neurons that control appetite. BMB Rep. 2015;48(4):229\u201333. https:\/\/doi.org\/10.5483\/bmbrep.2015.48.4.272.","journal-title":"BMB Rep"},{"issue":"12","key":"9975_CR55","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.tem.2021.09.005","volume":"32","author":"B Basu","year":"2021","unstructured":"Basu B, Jain M, Chopra AR. Caudamins, a new subclass of protein hormones. Trends Endocrinol Metab. 2021;32(12):1007\u201314. https:\/\/doi.org\/10.1016\/j.tem.2021.09.005.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"9975_CR56","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5607\/en23040","volume":"32","author":"J Song","year":"2023","unstructured":"Song J, Choi S-Y. Arcuate Nucleus of the Hypothalamus: Anatomy, Physiology, and Diseases. Exp Neurobiol. 2023;32(6):371\u201386. https:\/\/doi.org\/10.5607\/en23040.","journal-title":"Exp Neurobiol"},{"issue":"5","key":"9975_CR57","doi-asserted-by":"publisher","first-page":"E827","DOI":"10.1152\/ajpendo.00670.2007","volume":"294","author":"JW Hill","year":"2008","unstructured":"Hill JW, Elmquist JK, Elias CF. Hypothalamic pathways linking energy balance and reproduction. Am J Physiol Endocrinol Metab. 2008;294(5):E827\u201332. https:\/\/doi.org\/10.1152\/ajpendo.00670.2007.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9975_CR58","doi-asserted-by":"publisher","first-page":"111451","DOI":"10.1016\/j.mce.2021.111451","volume":"538","author":"T Keskin","year":"2021","unstructured":"Keskin T, Erden Y, Tekin S. Intracerebroventricular asprosin administration strongly stimulates hypothalamic-pituitary-testicular axis in rats. Mol Cell Endocrinol. 2021;538:111451. https:\/\/doi.org\/10.1016\/j.mce.2021.111451.","journal-title":"Mol Cell Endocrinol"},{"key":"9975_CR59","doi-asserted-by":"publisher","first-page":"171293","DOI":"10.1016\/j.peptides.2024.171293","volume":"181","author":"A Banerjee","year":"2024","unstructured":"Banerjee A, Chauhan V, Anamika M. Tripathy, Rai U. Asprosin-mediated regulation of ovarian functions in mice: An age-dependent study. Peptides. 2024;181:171293. https:\/\/doi.org\/10.1016\/j.peptides.2024.171293.","journal-title":"Peptides"},{"key":"9975_CR60","doi-asserted-by":"publisher","first-page":"111890","DOI":"10.1016\/j.mce.2023.111890","volume":"565","author":"IM Batalha","year":"2023","unstructured":"Batalha IM, Maylem ERS, Spicer LJ, Pena Bello CA, Archilia EC, Sch\u00fctz LF. Effects of asprosin on estradiol and progesterone secretion and proliferation of bovine granulosa cells. Mol Cell Endocrinol. 2023;565:111890. https:\/\/doi.org\/10.1016\/j.mce.2023.111890.","journal-title":"Mol. Cell. Endocrinol."},{"issue":"11","key":"9975_CR61","doi-asserted-by":"publisher","first-page":"e14579","DOI":"10.1111\/and.14579","volume":"54","author":"S Maurya","year":"2022","unstructured":"Maurya S, Krishna A, Lal B, Singh A. Asprosin promotes steroidogenesis and spermatogenesis with improved glucose metabolism in adult mice testis. Andrologia. 2022;54(11):e14579. https:\/\/doi.org\/10.1111\/and.14579.","journal-title":"Andrologia"},{"issue":"1","key":"9975_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41421-019-0122-x","volume":"5","author":"F Wei","year":"2019","unstructured":"Wei F, Long A, Wang Y. The Asprosin-OLFR734 hormonal signaling axis modulates male fertility. Cell Discov. 2019;5(1):55. https:\/\/doi.org\/10.1038\/s41421-019-0122-x.","journal-title":"Cell Discov"},{"key":"9975_CR63","doi-asserted-by":"publisher","first-page":"114036","DOI":"10.1016\/j.ygcen.2022.114036","volume":"323\u2013324","author":"S Maurya","year":"2022","unstructured":"Maurya S, Singh A. Asprosin modulates testicular functions during ageing in mice. Gen Comp Endocrinol. 2022;323\u2013324:114036. https:\/\/doi.org\/10.1016\/j.ygcen.2022.114036.","journal-title":"Gen Comp Endocrinol"},{"key":"9975_CR64","doi-asserted-by":"publisher","unstructured":"P. Sathoria, B. Chuphal, U. Rai, and B. Roy, \u201cAsprosin regulates male reproduction in teleosts: an in vitro study in Channa punctata.,\u201d J. Endocrinol., vol. 263, no. 3, Dec. 2024. https:\/\/doi.org\/10.1530\/JOE-24-0146.","DOI":"10.1530\/JOE-24-0146"},{"issue":"1","key":"9975_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/JME-20-0218","volume":"66","author":"ERS Maylem","year":"2021","unstructured":"Maylem ERS, Spicer LJ, Batalha I, Schutz LF. Discovery of a possible role of asprosin in ovarian follicular function. J Mol Endocrinol. 2021;66(1):35\u201344. https:\/\/doi.org\/10.1530\/JME-20-0218.","journal-title":"J Mol Endocrinol"},{"key":"9975_CR66","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.theriogenology.2021.11.004","volume":"178","author":"ERS Maylem","year":"2022","unstructured":"Maylem ERS, Spicer LJ, Atabay EP, Atabay EC, Batalha I, Schutz LF. A potential role of fibrillin-1 (FBN1) mRNA and asprosin in follicular development in water buffalo. Theriogenology. 2022;178:67\u201372. https:\/\/doi.org\/10.1016\/j.theriogenology.2021.11.004.","journal-title":"Theriogenology"},{"issue":"3","key":"9975_CR67","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00421-020-04570-8","volume":"121","author":"AN Leonard","year":"2021","unstructured":"Leonard AN, Shill AL, Thackray AE, Stensel DJ, Bishop NC. Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women. Eur J Appl Physiol. 2021;121(3):793\u2013801. https:\/\/doi.org\/10.1007\/s00421-020-04570-8.","journal-title":"Eur J Appl Physiol"},{"key":"9975_CR68","doi-asserted-by":"publisher","first-page":"106791","DOI":"10.1016\/j.domaniend.2023.106791","volume":"84\u201385","author":"ERS Maylem","year":"2023","unstructured":"Maylem ERS, Spicer LJ, Batalha IM, Sch\u00fctz LF. Developmental and hormonal regulation of FBN1 and OR4M1 mRNA in bovine granulosa cells. Domest Anim Endocrinol. 2023;84\u201385:106791. https:\/\/doi.org\/10.1016\/j.domaniend.2023.106791.","journal-title":"Domest Anim Endocrinol"},{"issue":"3\u20134","key":"9975_CR69","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s0378-4320(03)00092-7","volume":"78","author":"M Mihm","year":"2003","unstructured":"Mihm M, Bleach ECL. Endocrine regulation of ovarian antral follicle development in cattle. Anim Reprod Sci. 2003;78(3\u20134):217\u201337. https:\/\/doi.org\/10.1016\/s0378-4320(03)00092-7.","journal-title":"Anim Reprod Sci"},{"issue":"7","key":"9975_CR70","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1210\/mend.10.7.8813730","volume":"10","author":"J Baker","year":"1996","unstructured":"Baker J, et al. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol. 1996;10(7):903\u201318. https:\/\/doi.org\/10.1210\/mend.10.7.8813730.","journal-title":"Mol Endocrinol"},{"issue":"7","key":"9975_CR71","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1210\/mend.12.7.0138","volume":"12","author":"RL Robker","year":"1998","unstructured":"Robker RL, Richards JS. Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol. 1998;12(7):924\u201340. https:\/\/doi.org\/10.1210\/mend.12.7.0138.","journal-title":"Mol Endocrinol"},{"issue":"1","key":"9975_CR72","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/cdd.2017.172","volume":"25","author":"K Engeland","year":"2018","unstructured":"Engeland K. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM. Cell Death Differ. 2018;25(1):114\u201332. https:\/\/doi.org\/10.1038\/cdd.2017.172.","journal-title":"Cell Death Differ"},{"key":"9975_CR73","doi-asserted-by":"publisher","unstructured":"H. Kelestimur, Z. D. Oz, M. R. Ozdede, I. Serhatlioglu, N. K. Tektemur, and E. Kacar, \u201cFRI390 The Effects Of Chronic Asprosin Administration On Ovarian Tissue,\u201d J. Endocr. Soc., vol. 7, no. Supplement_1, p. bvad114.1584, Nov. 2023. https:\/\/doi.org\/10.1210\/jendso\/bvad114.1584.","DOI":"10.1210\/jendso\/bvad114.1584"},{"key":"9975_CR74","doi-asserted-by":"publisher","unstructured":"G. H. Goossens and E. E. Blaak, \u201cAdipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen?,\u201d Front. Endocrinol. (Lausanne)., vol. 6, p. 55, 2015. https:\/\/doi.org\/10.3389\/fendo.2015.00055.","DOI":"10.3389\/fendo.2015.00055"},{"key":"9975_CR75","doi-asserted-by":"publisher","unstructured":"I. S. Nedeva et al., \u201cCirculating Asprosin Concentrations in Patients with Obesity and Carbohydrate Disturbances.,\u201d Horm. Metab. Res. = Horm. und Stoffwechselforsch. = Horm. Metab., vol. 55, no. 4, pp. 284\u2013289, Apr. 2023. https:\/\/doi.org\/10.1055\/a-2033-6109.","DOI":"10.1055\/a-2033-6109"},{"issue":"1","key":"9975_CR76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5603\/EP.a2022.0093","volume":"74","author":"G Hu","year":"2023","unstructured":"Hu G, Si W, Zhang Q, Lv F. Circulating asprosin, irisin, and abdominal obesity in Chinese patients with type 2 diabetes mellitus: a case-control study. Endokrynol Pol. 2023;74(1):55\u201362. https:\/\/doi.org\/10.5603\/EP.a2022.0093.","journal-title":"Endokrynol Pol"},{"issue":"8","key":"9975_CR77","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/oby.23471","volume":"30","author":"H Cantay","year":"2022","unstructured":"Cantay H, Binnetoglu K, Gul HF, Bingol SA. Investigation of serum and adipose tissue levels of asprosin in patients with severe obesity undergoing sleeve gastrectomy. Obesity (Silver Spring). 2022;30(8):1639\u201346. https:\/\/doi.org\/10.1002\/oby.23471.","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"9975_CR78","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41366-018-0248-1","volume":"43","author":"C-Y Wang","year":"2019","unstructured":"Wang C-Y, et al. Serum asprosin levels and bariatric surgery outcomes in obese adults. Int J Obes (Lond). 2019;43(5):1019\u201325. https:\/\/doi.org\/10.1038\/s41366-018-0248-1.","journal-title":"Int J Obes (Lond)"},{"key":"9975_CR79","doi-asserted-by":"publisher","first-page":"896735","DOI":"10.3389\/fphys.2022.896735","volume":"13","author":"T Yao","year":"2022","unstructured":"Yao T, et al. Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic- pituitary-gonad-axis dysfunction in obese men. Front Physiol. 2022;13:896735. https:\/\/doi.org\/10.3389\/fphys.2022.896735.","journal-title":"Front Physiol"},{"issue":"4","key":"9975_CR80","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000503808","volume":"75","author":"M Wang","year":"2019","unstructured":"Wang M, et al. Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity. Ann Nutr Metab. 2019;75(4):205\u201312. https:\/\/doi.org\/10.1159\/000503808.","journal-title":"Ann Nutr Metab"},{"issue":"4","key":"9975_CR81","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/ped.14176","volume":"62","author":"E S\u00fcnnet\u00e7i Silistre","year":"2020","unstructured":"S\u00fcnnet\u00e7i Silistre E, Hatipo\u011fl HU. Increased serum circulating asprosin levels in children with obesity. Pediatr Int. 2020;62(4):467\u201376. https:\/\/doi.org\/10.1111\/ped.14176.","journal-title":"Pediatr. Int."},{"issue":"5","key":"9975_CR82","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/labmed\/lmac152","volume":"54","author":"N Moradi","year":"2023","unstructured":"Moradi N, et al. Meteorin-like Protein and Asprosin Levels in Children and Adolescents with Obesity and Their Relationship with Insulin Resistance and Metabolic Syndrome. Lab Med. 2023;54(5):457\u201363. https:\/\/doi.org\/10.1093\/labmed\/lmac152.","journal-title":"Lab Med"},{"key":"9975_CR83","doi-asserted-by":"publisher","first-page":"1452277","DOI":"10.3389\/fendo.2024.1452277","volume":"15","author":"S-H Kim","year":"2024","unstructured":"Kim S-H, Kim SE, Chun YH. The association of plasma asprosin with anthropometric and metabolic parameters in Korean children and adolescents. Front Endocrinol (Lausanne). 2024;15:1452277. https:\/\/doi.org\/10.3389\/fendo.2024.1452277.","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"9975_CR84","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000500523","volume":"91","author":"W Long","year":"2019","unstructured":"Long W, et al. Decreased Circulating Levels of Asprosin in Obese Children. Horm Res Paediatr. 2019;91(4):271\u20137. https:\/\/doi.org\/10.1159\/000500523.","journal-title":"Horm Res Paediatr"},{"key":"9975_CR85","doi-asserted-by":"publisher","unstructured":"S. Suren Garg, K. Kushwaha, R. Dubey, and J. Gupta, \u201cAssociation between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions.,\u201d Diabetes Res. Clin. Pract., vol. 200, p. 110691, Jun. 2023. https:\/\/doi.org\/10.1016\/j.diabres.2023.110691.","DOI":"10.1016\/j.diabres.2023.110691"},{"key":"9975_CR86","doi-asserted-by":"publisher","unstructured":"M. Mirr et al., \u201cSerum Asprosin Correlates with Indirect Insulin Resistance Indices.,\u201d Biomedicines, vol. 11, no. 6, May 2023, https:\/\/doi.org\/10.3390\/biomedicines11061568.","DOI":"10.3390\/biomedicines11061568"},{"key":"9975_CR87","doi-asserted-by":"publisher","unstructured":"A. I. Mazur-Bialy, \u201cAsprosin Enhances Cytokine Production by a Co-Culture of Fully Differentiated Mature Adipocytes and Macrophages Leading to the Exacerbation of the Condition Typical of Obesity-Related Inflammation.,\u201d Int. J. Mol. Sci., vol. 24, no. 6, Mar. 2023. https:\/\/doi.org\/10.3390\/ijms24065745.","DOI":"10.3390\/ijms24065745"},{"key":"9975_CR88","doi-asserted-by":"publisher","first-page":"726783","DOI":"10.3389\/fphys.2021.726783","volume":"12","author":"M Kantorowicz","year":"2021","unstructured":"Kantorowicz M, Szymura J, Szygula Z, Kusmierczyk J, Maciejczyk M, Wiecek M. Nordic Walking at Maximal Fat Oxidation Intensity Decreases Circulating Asprosin and Visceral Obesity in Women With Metabolic Disorders. Front Physiol. 2021;12:726783. https:\/\/doi.org\/10.3389\/fphys.2021.726783.","journal-title":"Front Physiol"},{"issue":"1","key":"9975_CR89","doi-asserted-by":"publisher","first-page":"28109","DOI":"10.1038\/s41598-024-79853-7","volume":"14","author":"A Suder","year":"2024","unstructured":"Suder A, Makiel K, Targosz A, Kosowski P, Malina RM. Effects of exercise and dietary interventions on asprosin, leptin, and lipid metabolism in males with abdominal obesity, a randomized controlled trial. Sci Rep. 2024;14(1):28109. https:\/\/doi.org\/10.1038\/s41598-024-79853-7.","journal-title":"Sci. Rep."},{"issue":"3","key":"9975_CR90","doi-asserted-by":"publisher","first-page":"e101776","DOI":"10.5812\/ijem.101776","volume":"18","author":"M Amiri","year":"2020","unstructured":"Amiri M, Ramezani Tehrani F. Potential Adverse Effects of Female and Male Obesity on Fertility: A Narrative Review. Int J Endocrinol Metab. 2020;18(3):e101776. https:\/\/doi.org\/10.5812\/ijem.101776.","journal-title":"Int. J. Endocrinol. Metab."},{"key":"9975_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27\u201336. https:\/\/doi.org\/10.1016\/j.jsbmb.2018.04.008.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"9975_CR92","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439\u201373. https:\/\/doi.org\/10.1007\/s10815-022-02625-7.","journal-title":"J Assist Reprod Genet"},{"key":"9975_CR93","doi-asserted-by":"publisher","unstructured":"D. Armanini, M. Boscaro, L. Bordin, and C. Sabbadin, \u201cControversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism.,\u201d Int. J. Mol. Sci., vol. 23, no. 8, Apr. 2022. https:\/\/doi.org\/10.3390\/ijms23084110.","DOI":"10.3390\/ijms23084110"},{"issue":"3","key":"9975_CR94","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.5455\/medscience.2022.10.216","volume":"11","author":"M Gungor","year":"2022","unstructured":"Gungor M, Baskiran Y, Erol O. Investigation of serum asprosin level in patients diagnosed of polycystic ovary syndrome in adolescent age. Med Sci Int Med J. 2022;11(3):1725. https:\/\/doi.org\/10.5455\/medscience.2022.10.216.","journal-title":"Med. Sci. Int. Med. J."},{"issue":"15","key":"9975_CR95","doi-asserted-by":"publisher","first-page":"e33526","DOI":"10.1097\/MD.0000000000033526","volume":"102","author":"L Zhu","year":"2023","unstructured":"Zhu L, Wang L. Serum asprosin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome: A retrospective case-control study. Medicine (Baltimore). 2023;102(15):e33526. https:\/\/doi.org\/10.1097\/MD.0000000000033526.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"9975_CR96","doi-asserted-by":"publisher","first-page":"2152790","DOI":"10.1080\/09513590.2022.2152790","volume":"39","author":"FR P\u00e9rez-L\u00f3pez","year":"2023","unstructured":"P\u00e9rez-L\u00f3pez FR, L\u00f3pez-Baena MT, P\u00e9rez-Roncero GR, Chedraui P, Varikasuvu SR, Garc\u00eda-Alfaro P. Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2023;39(1):2152790. https:\/\/doi.org\/10.1080\/09513590.2022.2152790.","journal-title":"Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol."},{"issue":"3","key":"9975_CR97","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/09513590.2018.1512967","volume":"35","author":"M Alan","year":"2019","unstructured":"Alan M, et al. Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2019;35(3):220\u20133. https:\/\/doi.org\/10.1080\/09513590.2018.1512967.","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"key":"9975_CR98","doi-asserted-by":"publisher","first-page":"9471583","DOI":"10.1155\/2018\/9471583","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion. Mediators Inflamm. 2018;2018:9471583. https:\/\/doi.org\/10.1155\/2018\/9471583.","journal-title":"Mediators Inflamm"},{"issue":"3","key":"9975_CR99","doi-asserted-by":"publisher","first-page":"613","DOI":"10.5114\/aoms.2019.82672","volume":"15","author":"KC Lewandowski","year":"2019","unstructured":"Lewandowski KC, et al. How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models. Arch Med Sci. 2019;15(3):613\u20138. https:\/\/doi.org\/10.5114\/aoms.2019.82672.","journal-title":"Arch Med Sci"},{"issue":"6","key":"9975_CR100","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1097\/j.pbj.0000000000000108","volume":"5","author":"C Lu\u00eds","year":"2020","unstructured":"Lu\u00eds C, Fernandes R, Soares R, von Hafe P. A state of the art review on the novel mediator asprosin in the metabolic syndrome. Porto Biomed J. 2020;5(6):e108. https:\/\/doi.org\/10.1097\/j.pbj.0000000000000108.","journal-title":"Porto Biomed. J."},{"issue":"4","key":"9975_CR101","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1590\/1806-9282.20201147","volume":"67","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Liu Y, Yu Z, Yang P, Zhao S. Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study. Rev Assoc Med Bras. 2021;67(4):590\u20136. https:\/\/doi.org\/10.1590\/1806-9282.20201147.","journal-title":"Rev Assoc Med Bras"},{"issue":"1","key":"9975_CR102","doi-asserted-by":"publisher","first-page":"6447","DOI":"10.1038\/s41598-019-42061-9","volume":"9","author":"CL Chang","year":"2019","unstructured":"Chang CL, Huang SY, Hsu YC, Chin TH, Soong YK. The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients. Sci Rep. 2019;9(1):6447. https:\/\/doi.org\/10.1038\/s41598-019-42061-9.","journal-title":"Sci. Rep."},{"issue":"3","key":"9975_CR103","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3892\/ol.2021.12911","volume":"22","author":"R Kerslake","year":"2021","unstructured":"Kerslake R, et al. A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancer. Oncol Lett. 2021;22(3):650. https:\/\/doi.org\/10.3892\/ol.2021.12911.","journal-title":"Oncol. Lett."},{"key":"9975_CR104","doi-asserted-by":"publisher","first-page":"1302285","DOI":"10.3389\/fcell.2023.1302285","volume":"11","author":"L Li","year":"2023","unstructured":"Li L, Huang J, Liu Y. The extracellular matrix glycoprotein fibrillin-1 in health and disease. Front cell Dev Biol. 2023;11:1302285. https:\/\/doi.org\/10.3389\/fcell.2023.1302285.","journal-title":"Front cell Dev Biol"},{"issue":"9","key":"9975_CR105","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.18632\/oncotarget.3118","volume":"6","author":"Z Wang","year":"2015","unstructured":"Wang Z, et al. Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis. Oncotarget. 2015;6(9):6670\u201383. https:\/\/doi.org\/10.18632\/oncotarget.3118.","journal-title":"Oncotarget"},{"issue":"9","key":"9975_CR106","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.annonc.2020.05.019","volume":"31","author":"J Millstein","year":"2020","unstructured":"Millstein J, et al. Prognostic gene expression signature for high-grade serous ovarian cancer. Ann Oncol Off J Eur Soc Med Oncol. 2020;31(9):1240\u201350. https:\/\/doi.org\/10.1016\/j.annonc.2020.05.019.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"9975_CR107","doi-asserted-by":"publisher","unstructured":"Z. Wang et al., (2022) \u201cThe Fibrillin-1\/VEGFR2\/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells,\u201d Cancer Commun. (London, England), 42(3), 245\u2013265, https:\/\/doi.org\/10.1002\/cac2.12274.","DOI":"10.1002\/cac2.12274"},{"key":"9975_CR108","doi-asserted-by":"publisher","unstructured":"M. A. Hossain, S. M. Saiful Islam, J. M. W. Quinn, F. Huq, and M. A. Moni, \u201cMachine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.,\u201d J. Biomed. Inform., vol. 100, p. 103313, Dec. 2019. https:\/\/doi.org\/10.1016\/j.jbi.2019.103313.","DOI":"10.1016\/j.jbi.2019.103313"},{"issue":"2","key":"9975_CR109","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/10520295.2022.2135763","volume":"98","author":"M Mirzaoglu","year":"2023","unstructured":"Mirzaoglu M, et al. Use of asprosin and subfatin for differential diagnosis of serous ovarian tumors. Biotech Histochem Off Publ Biol Stain Comm. 2023;98(2):140\u20136. https:\/\/doi.org\/10.1080\/10520295.2022.2135763.","journal-title":"Biotech. Histochem. Off. Publ. Biol. Stain Comm."},{"key":"9975_CR110","doi-asserted-by":"publisher","unstructured":"C. La Vecchia, (2017) \u201cOvarian cancer: epidemiology and risk factors,\u201d Eur. J. cancer Prev. Off. J. Eur. Cancer Prev. Organ., 26(1):55\u201362. https:\/\/doi.org\/10.1097\/CEJ.0000000000000217.","DOI":"10.1097\/CEJ.0000000000000217"},{"key":"9975_CR111","doi-asserted-by":"publisher","unstructured":"R. Kerslake et al., \u201cDifferential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian Cancer.,\u201d J. Clin. Med., vol. 11, no. 19, Oct. 2022. https:\/\/doi.org\/10.3390\/jcm11195942.","DOI":"10.3390\/jcm11195942"},{"key":"9975_CR112","doi-asserted-by":"publisher","unstructured":"S. Hutt, D. Mihaies, E. Karteris, A. Michael, A. M. Payne, and J. Chatterjee, \u201cStatistical Meta-Analysis of Risk Factors for Endometrial Cancer and Development of a Risk Prediction Model Using an Artificial Neural Network Algorithm.,\u201d Cancers (Basel)., vol. 13, no. 15, Jul. 2021. https:\/\/doi.org\/10.3390\/cancers13153689.","DOI":"10.3390\/cancers13153689"},{"key":"9975_CR113","doi-asserted-by":"crossref","unstructured":"E. Onat, N. Kocaman, and H. Balta, \u201cThe Role Of Meteorin-Like Peptide And Asprosin \u0130n The Diagnosis Of Endometrium Carcinoma,\u201d Chronicles Precis. Med. Res., vol. 4, no. 3, Nov. 2023. doi: 10.5281\/zenodo.10020925.","DOI":"10.7759\/cureus.47073"},{"issue":"5","key":"9975_CR114","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/cam4.1445","volume":"7","author":"JN Painter","year":"2018","unstructured":"Painter JN, et al. Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. Cancer Med. 2018;7(5):1978\u201387. https:\/\/doi.org\/10.1002\/cam4.1445.","journal-title":"Cancer Med"},{"issue":"30","key":"9975_CR115","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1038\/onc.2014.326","volume":"34","author":"S Zhao","year":"2015","unstructured":"Zhao S, Sedwick D, Wang Z. Genetic alterations of protein tyrosine phosphatases in human cancers. Oncogene. 2015;34(30):3885\u201394. https:\/\/doi.org\/10.1038\/onc.2014.326.","journal-title":"Oncogene"},{"key":"9975_CR116","doi-asserted-by":"publisher","unstructured":"S. Orton et al., \u201cIn Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and Neuroblastoma.,\u201d Cancers (Basel)., vol. 16, no. 3, Jan. 2024. https:\/\/doi.org\/10.3390\/cancers16030582.","DOI":"10.3390\/cancers16030582"},{"issue":"6","key":"9975_CR117","doi-asserted-by":"publisher","first-page":"6","DOI":"10.7759\/cureus.62979","volume":"16","author":"N Kocaman","year":"2024","unstructured":"Kocaman N, Onat E, Balta H, \u00dc\u00e7er \u00d6. Are Meteorin-Like Peptide and Asprosin Important in the Diagnosis of Breast Tumors? Cureus. 2024;16(6):6\u201310. https:\/\/doi.org\/10.7759\/cureus.62979.","journal-title":"Cureus"},{"key":"9975_CR118","doi-asserted-by":"publisher","unstructured":"L. Neves Rebello Alves et al., \u201cBiomarkers in Breast Cancer: An Old Story with a New End.,\u201d Genes (Basel)., vol. 14, no. 7, Jun. 2023. https:\/\/doi.org\/10.3390\/genes14071364.","DOI":"10.3390\/genes14071364"},{"issue":"2","key":"9975_CR119","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12272-019-01122-3","volume":"42","author":"G Kim","year":"2019","unstructured":"Kim G, Bhattarai PY, Choi HS. Peptidyl-prolyl cis\/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer. Arch Pharm Res. 2019;42(2):128\u201339. https:\/\/doi.org\/10.1007\/s12272-019-01122-3.","journal-title":"Arch Pharm Res"},{"key":"9975_CR120","doi-asserted-by":"publisher","first-page":"101855","DOI":"10.1016\/j.tice.2022.101855","volume":"77","author":"G Akkus","year":"2022","unstructured":"Akkus G, Koyuturk LC, Yilmaz M, Hancer S, Ozercan IH, Kuloglu T. Asprosin and meteorin-like protein immunoreactivity in invasive ductal breast carcinoma stages. Tissue Cell. 2022;77:101855. https:\/\/doi.org\/10.1016\/j.tice.2022.101855.","journal-title":"Tissue Cell"},{"key":"9975_CR121","doi-asserted-by":"publisher","unstructured":"N. Kocaman, E. Onat, and H. Balta, (2024) \u201cAre Meteorin-Like Peptide and Asprosin Important in the Diagnosis of Breast Tumors\u202f? Immunohistochemical findings,\u201d 16(6):6\u201311. https:\/\/doi.org\/10.7759\/cureus.62979.","DOI":"10.7759\/cureus.62979"},{"issue":"2","key":"9975_CR122","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1089\/jwh.2023.0178","volume":"33","author":"M Yur","year":"2024","unstructured":"Yur M, \u00d6zcan S, Y\u0131ld\u0131r\u0131m N, \u00d6zdede MR, \u00d6zcan M. Elevated Asprosin Levels in Breast Cancer: Insights from a Comparative Study. J Womens Health (Larchmt). 2024;33(2):254\u201361. https:\/\/doi.org\/10.1089\/jwh.2023.0178.","journal-title":"J Womens Health (Larchmt)"},{"issue":"11","key":"9975_CR123","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41574-019-0245-z","volume":"15","author":"C Chapron","year":"2019","unstructured":"Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15(11):666\u201382. https:\/\/doi.org\/10.1038\/s41574-019-0245-z.","journal-title":"Nat Rev Endocrinol"},{"key":"9975_CR124","doi-asserted-by":"crossref","unstructured":"A. Alg\u0131n, S. Ozdemir, H. S. Akca, N. M. Hokenek, K. Kokulu, and M. Ozgur, \u201cThe assessment of plasma asprosin levels in acute coronary artery disease and its correlation with HEART score,\u201d pp. 43\u201347, 2022.","DOI":"10.23950\/jcmk\/11939"},{"key":"9975_CR125","doi-asserted-by":"publisher","unstructured":"P. R. de C. Fran\u00e7a, A. C. P. Lontra, and P. D. Fernandes, \u201cEndometriosis: A Disease with Few Direct Treatment Options.,\u201d Molecules, vol. 27, no. 13, Jun. 2022. https:\/\/doi.org\/10.3390\/molecules27134034.","DOI":"10.3390\/molecules27134034"},{"issue":"4","key":"9975_CR126","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000102174","volume":"185","author":"CL Stumm","year":"2007","unstructured":"Stumm CL, Zorn TMT. Changes in fibrillin-1 in the endometrium during the early stages of pregnancy in mice. Cells Tissues Organs. 2007;185(4):258\u201368. https:\/\/doi.org\/10.1159\/000102174.","journal-title":"Cells Tissues Organs"},{"issue":"3","key":"9975_CR127","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.autrev.2010.09.003","volume":"10","author":"MA Atanasova","year":"2011","unstructured":"Atanasova MA, Konova EI, Aleksovska TA, Todorova KN, Georgieva MN, Lukanov TH. Anti-fibrillin-1 autoantibodies in normal pregnancy and recurrent pregnancy loss. Autoimmun Rev. 2011;10(3):131\u20136. https:\/\/doi.org\/10.1016\/j.autrev.2010.09.003.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"9975_CR128","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1210\/en.2006-1692","volume":"148","author":"RO Burney","year":"2007","unstructured":"Burney RO, et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007;148(8):3814\u201326. https:\/\/doi.org\/10.1210\/en.2006-1692.","journal-title":"Endocrinology"},{"key":"9975_CR129","doi-asserted-by":"publisher","unstructured":"S. Kaplan, P. K\u0131r\u0131c\u0131, and A. T\u00fcrk, \u201cThe effects of adalimumab on the rat autotransplantation endometriosis model: A placebo-controlled randomized study,\u201d Adv. Clin. Exp. Med., vol. 31, no. 4, 2022. https:\/\/doi.org\/10.17219\/acem\/144369.","DOI":"10.17219\/acem\/144369"},{"key":"9975_CR130","doi-asserted-by":"publisher","unstructured":"V. Kaartinen and D. Warburton, \u201cFibrillin controls TGF-beta activation.,\u201d Nature genetics, vol. 33, no. 3. United States, pp. 331\u2013332, Mar. 2003. https:\/\/doi.org\/10.1038\/ng0303-331.","DOI":"10.1038\/ng0303-331"},{"issue":"3","key":"9975_CR131","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1083\/jcb.200608167","volume":"176","author":"SS Chaudhry","year":"2007","unstructured":"Chaudhry SS, Cain SA, Morgan A, Dallas SL, Shuttleworth CA, Kielty CM. Fibrillin-1 regulates the bioavailability of TGFbeta1. J Cell Biol. 2007;176(3):355\u201367. https:\/\/doi.org\/10.1083\/jcb.200608167.","journal-title":"J Cell Biol"},{"issue":"3","key":"9975_CR132","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bjps.2003.12.012","volume":"57","author":"D Chin","year":"2004","unstructured":"Chin D, Boyle GM, Parsons PG, Coman WB. What is transforming growth factor-beta (TGF-\u03b2)? Br J Plast Surg. 2004;57(3):215\u201321. https:\/\/doi.org\/10.1016\/j.bjps.2003.12.012.","journal-title":"Br J Plast Surg"},{"issue":"5","key":"9975_CR133","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/humupd\/dmx016","volume":"23","author":"VJ Young","year":"2017","unstructured":"Young VJ, Ahmad SF, Duncan WC, Horne AW. The role of TGF-\u03b2 in the pathophysiology of peritoneal endometriosis. Hum Reprod Update. 2017;23(5):548\u201359. https:\/\/doi.org\/10.1093\/humupd\/dmx016.","journal-title":"Hum Reprod Update"},{"issue":"7","key":"9975_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0181166","volume":"12","author":"M Renard","year":"2017","unstructured":"Renard M, et al. Sex, pregnancy and aortic disease in Marfan syndrome. PLoS ONE. 2017;12(7):1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0181166.","journal-title":"PLoS ONE"},{"key":"9975_CR135","doi-asserted-by":"publisher","unstructured":"M. You et al., \u201cAsprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease.,\u201d Cardiovasc. Diabetol., vol. 21, no. 1, p. 25, Feb. 2022. https:\/\/doi.org\/10.1186\/s12933-022-01457-0.","DOI":"10.1186\/s12933-022-01457-0"},{"key":"9975_CR136","doi-asserted-by":"publisher","unstructured":"B. Li, Y. Zhang, L. Zhang, and L. Zhang, \u201cAssociation between endometriosis and metabolic syndrome: a cross-sectional study based on the National Health and Nutrition Examination Survey data,\u201d Gynecol. Endocrinol., vol. 39, no. 1, p., 2023. https:\/\/doi.org\/10.1080\/09513590.2023.2254844.","DOI":"10.1080\/09513590.2023.2254844"},{"issue":"3","key":"9975_CR137","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1515\/jbcpp-2022-0219","volume":"34","author":"A Ahmad","year":"2023","unstructured":"Ahmad A, et al. Diagnosis and management of uterine fibroids: current trends and future strategies. J Basic Clin Physiol Pharmacol. 2023;34(3):291\u2013310. https:\/\/doi.org\/10.1515\/jbcpp-2022-0219.","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"46","key":"9975_CR138","doi-asserted-by":"publisher","first-page":"e5325","DOI":"10.1097\/MD.0000000000005325","volume":"95","author":"YJ Tak","year":"2016","unstructured":"Tak YJ, et al. Association between uterine leiomyoma and metabolic syndrome in parous premenopausal women: A case-control study. Medicine (Baltimore). 2016;95(46):e5325. https:\/\/doi.org\/10.1097\/MD.0000000000005325.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"9975_CR139","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/molehr\/gam007","volume":"13","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Wen Y, Polan ML, Qiao J, Chen BH. Increased expression of latent TGF-\u00df binding protein-1 and fibrillin-1 in human uterine leiomyomata. Mol Hum Reprod. 2007;13(5):343\u20139. https:\/\/doi.org\/10.1093\/molehr\/gam007.","journal-title":"Mol Hum Reprod"},{"issue":"9","key":"9975_CR140","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1210\/jcem.81.9.8784073","volume":"81","author":"Q Dou","year":"1996","unstructured":"Dou Q, et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab. 1996;81(9):3222\u201330. https:\/\/doi.org\/10.1210\/jcem.81.9.8784073.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9975_CR141","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.fertnstert.2009.05.001","volume":"94","author":"J Yen-Ping Ho","year":"2010","unstructured":"Yen-Ping Ho J, Man WC, Wen Y, Polan ML, Shih-Chu Ho E, Chen B. Transforming growth interacting factor expression in leiomyoma compared with myometrium. Fertil Steril. 2010;94(3):1078\u201383. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.05.001.","journal-title":"Fertil. Steril."},{"issue":"9","key":"9975_CR142","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1177\/1933719116678686","volume":"24","author":"MA Borahay","year":"2017","unstructured":"Borahay MA, Asoglu MR, Mas A, Adam S, Kilic GS, Al-Hendy A. Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications. Reprod Sci. 2017;24(9):1235\u201344. https:\/\/doi.org\/10.1177\/1933719116678686.","journal-title":"Reprod Sci"},{"issue":"2","key":"9975_CR143","first-page":"142","volume":"8","author":"R Dumitrescu","year":"2015","unstructured":"Dumitrescu R, Mehedintu C, Briceag I, Purcarea VL, Hudita D. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms. J Med Life. 2015;8(2):142\u20135.","journal-title":"J Med Life"},{"key":"9975_CR144","unstructured":"L. I. Rasquin, C. Anastasopoulou, and J. V Mayrin, \u201cPolycystic Ovarian Disease.,\u201d Treasure Island (FL), 2024."},{"issue":"5","key":"9975_CR145","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.fertnstert.2006.11.012","volume":"87","author":"LA Wise","year":"2007","unstructured":"Wise LA, Palmer JR, Stewart EA, Rosenberg L. Polycystic ovary syndrome and risk of uterine leiomyomata. Fertil Steril. 2007;87(5):1108\u201315. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.11.012.","journal-title":"Fertil Steril"},{"key":"9975_CR146","doi-asserted-by":"publisher","first-page":"7375294","DOI":"10.1155\/2018\/7375294","volume":"2018","author":"X Li","year":"2018","unstructured":"Li X, et al. Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases. Mediators Inflamm. 2018;2018:7375294. https:\/\/doi.org\/10.1155\/2018\/7375294.","journal-title":"Mediators Inflamm"},{"key":"9975_CR147","first-page":"63","volume":"343","author":"B Mahmmoed","year":"2023","unstructured":"Mahmmoed B, Hilal N, Sarhat E. EVALUATION OF FETUIN-A LEVEL IN POLYCYSTIC OVARY SYNDROME AND ITS ASSOCIATION WITH ASPROSIN AND SOME BIOCHEMICAL PARAMETERS. Georgian Med News. 2023;343:63\u20136.","journal-title":"Georgian Med News"},{"issue":"2","key":"9975_CR148","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/01443615.2020.1758926","volume":"41","author":"R Deniz","year":"2021","unstructured":"Deniz R, et al. Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome. J Obstet Gynaecol J Inst Obstet Gynaecol. 2021;41(2):279\u201384. https:\/\/doi.org\/10.1080\/01443615.2020.1758926.","journal-title":"J Obstet Gynaecol J Inst Obstet Gynaecol"},{"issue":"2","key":"9975_CR149","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1530\/JOE-18-0032","volume":"238","author":"P \u0160imj\u00e1k","year":"2018","unstructured":"\u0160imj\u00e1k P, et al. The role of obesity and adipose tissue dysfunction in gestational diabetes mellitus. J Endocrinol. 2018;238(2):R63\u201377. https:\/\/doi.org\/10.1530\/JOE-18-0032.","journal-title":"J Endocrinol"},{"issue":"6","key":"9975_CR150","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2105\/AJPH.2009.172890","volume":"100","author":"SY Kim","year":"2010","unstructured":"Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health. 2010;100(6):1047\u201352. https:\/\/doi.org\/10.2105\/AJPH.2009.172890.","journal-title":"Am J Public Health"},{"key":"9975_CR151","doi-asserted-by":"publisher","unstructured":"D. S. Feig, \u201cFaster and faster: meeting the challenges of delayed insulin action during pregnancy.,\u201d lancet. Diabetes Endocrinol., vol. 11, no. 11, pp. 785\u2013787, Nov. 2023. https:\/\/doi.org\/10.1016\/S2213-8587(23)00259-0.","DOI":"10.1016\/S2213-8587(23)00259-0"},{"key":"9975_CR152","doi-asserted-by":"publisher","first-page":"916042","DOI":"10.3389\/fendo.2022.916042","volume":"13","author":"I Mart\u00edn-Estal","year":"2022","unstructured":"Mart\u00edn-Estal I, Castorena-Torres F. Gestational Diabetes Mellitus and Energy-Dense Diet: What Is the Role of the Insulin\/IGF Axis? Front Endocrinol (Lausanne). 2022;13:916042. https:\/\/doi.org\/10.3389\/fendo.2022.916042.","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"9975_CR153","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.placenta.2020.02.004","volume":"93","author":"L Zhong","year":"2020","unstructured":"Zhong L, et al. Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: A nested case-control study. Placenta. 2020;93:17\u201322. https:\/\/doi.org\/10.1016\/j.placenta.2020.02.004.","journal-title":"Placenta"},{"key":"9975_CR154","doi-asserted-by":"publisher","unstructured":"\u0130. B. Boz, S. Ayt\u00fcrk Salt, \u00d6. Salt, N. C. Say\u0131n, and \u0130. Dibirdik, \u201cAssociation Between Plasma Asprosin Levels and Gestational Diabetes Mellitus.,\u201d Diabetes. Metab. Syndr. Obes., vol. 16, pp. 2515\u20132521, 2023. https:\/\/doi.org\/10.2147\/DMSO.S424651.","DOI":"10.2147\/DMSO.S424651"},{"key":"9975_CR155","doi-asserted-by":"publisher","unstructured":"T. Hoffmann et al., \u201cCorrelation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy.,\u201d Endocr. Connect., vol. 11, no. 3, Mar. 2022. https:\/\/doi.org\/10.1530\/EC-22-0069.","DOI":"10.1530\/EC-22-0069"},{"key":"9975_CR156","doi-asserted-by":"publisher","first-page":"170132","DOI":"10.1016\/j.peptides.2019.170132","volume":"120","author":"Y Baykus","year":"2019","unstructured":"Baykus Y, Yavuzkir S, Ustebay S, Ugur K, Deniz R, Aydin S. Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus. Peptides. 2019;120:170132. https:\/\/doi.org\/10.1016\/j.peptides.2019.170132.","journal-title":"Peptides"},{"issue":"5","key":"9975_CR157","doi-asserted-by":"publisher","first-page":"748","DOI":"10.24953\/turkjped.2023.275","volume":"65","author":"EE Yal\u0131nba\u015f","year":"2023","unstructured":"Yal\u0131nba\u015f EE, Akc\u0131lar R. Evaluation of the relationship between neonatal serum asprosin levels and anthropometric measurements in newborns of mothers with and without gestational diabetes mellitus. Turk J Pediatr. 2023;65(5):748\u201357. https:\/\/doi.org\/10.24953\/turkjped.2023.275.","journal-title":"Turk J Pediatr"},{"key":"9975_CR158","unstructured":"M. Y. Rezk, H. A. Elkattawy, and R. A. Fouad, \u201cPlasma Asprosin Levels Changes in Pregnant and Non-Pregnant Rats with and without Gestational Diabetes,\u201d Int. J. Med. Res. Heal. Sci., vol. 9, no. 3, pp. 54\u201363, 2020, [Online]. Available: https:\/\/www.ijmrhs.com\/abstract\/plasma-asprosin-levels-changes-in-pregnant-and-nonpregnant-rats-with-and-without-gestational-diabetes-44844.html"},{"issue":"4","key":"9975_CR159","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4328\/acam.22112","volume":"15","author":"E Uysal","year":"2024","unstructured":"Uysal E, Incesu Cintesun F, Gunenc O, CanV U. Investigation of serum asprosin level in gestational diabetes mellitus and examination of neonatal outcome. Ann Clin Anal Med. 2024;15(4):287\u201392. https:\/\/doi.org\/10.4328\/acam.22112.","journal-title":"Ann. Clin. Anal. Med."},{"issue":"4","key":"9975_CR160","doi-asserted-by":"publisher","first-page":"229","DOI":"10.18388\/pb.2018_146","volume":"64","author":"A Filipek","year":"2018","unstructured":"Filipek A, Jurewicz E. Preeclampsia - a disease of pregnant women. Postepy Biochem. 2018;64(4):229\u201332. https:\/\/doi.org\/10.18388\/pb.2018_146.","journal-title":"Postepy Biochem"},{"issue":"14","key":"9975_CR161","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","volume":"76","author":"CW Ives","year":"2020","unstructured":"Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;76(14):1690\u2013702. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.014.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"9975_CR162","first-page":"281","volume":"64","author":"W Hermes","year":"2012","unstructured":"Hermes W, Van Kesteren F, De Groot CJM. Preeclampsia and cardiovascular risk. Minerva Ginecol. 2012;64(4):281\u201392.","journal-title":"Minerva Ginecol"},{"issue":"4","key":"9975_CR163","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/HCO.0000000000000756","volume":"35","author":"S Neerukonda","year":"2020","unstructured":"Neerukonda S, Shariati F, Hart T, Stewart M, Elkayam U, Qamruddin S. Cardiovascular effects of preeclampsia. Curr Opin Cardiol. 2020;35(4):357\u20139. https:\/\/doi.org\/10.1097\/HCO.0000000000000756.","journal-title":"Curr Opin Cardiol"},{"issue":"2","key":"9975_CR164","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jri.2009.04.009","volume":"82","author":"M Scioscia","year":"2009","unstructured":"Scioscia M, Gumaa K, Rademacher TW. The link between insulin resistance and preeclampsia: new perspectives. J Reprod Immunol. 2009;82(2):100\u20135. https:\/\/doi.org\/10.1016\/j.jri.2009.04.009.","journal-title":"J Reprod Immunol"},{"issue":"2","key":"9975_CR165","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000357944","volume":"77","author":"E Vald\u00e9s","year":"2014","unstructured":"Vald\u00e9s E, Sep\u00falveda-Mart\u00ednez A, Manuki\u00e1n B, Parra-Cordero M. Assessment of pregestational insulin resistance as a risk factor of preeclampsia. Gynecol Obstet Invest. 2014;77(2):111\u20136. https:\/\/doi.org\/10.1159\/000357944.","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"9975_CR166","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/s-2007-1016251","volume":"16","author":"R Kaaja","year":"1998","unstructured":"Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol. 1998;16(1):41\u20136. https:\/\/doi.org\/10.1055\/s-2007-1016251.","journal-title":"Semin Reprod Endocrinol"},{"key":"9975_CR167","unstructured":"N. Shafi, F. Bano, and S. Uraneb, \u201cThe role of novel hormone asprosin in insulin resistance during preeclampsia.,\u201d Pak. J. Pharm. Sci., vol. 34, no. 3(Supplementary), pp. 1039\u20131043, May 2021."},{"key":"9975_CR168","unstructured":"F. B. Nida Sha , Rehana Mushtaq, \u201cPakistan biomedical journal,\u201d vol. 4, no. c, pp. 37\u201340, 2021."},{"issue":"6","key":"9975_CR169","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s43032-021-00756-3","volume":"30","author":"L Yang","year":"2023","unstructured":"Yang L, et al. Maternal Factors for Intrauterine Growth Retardation: Systematic Review and Meta-Analysis of Observational Studies. Reprod Sci. 2023;30(6):1737\u201345. https:\/\/doi.org\/10.1007\/s43032-021-00756-3.","journal-title":"Reprod Sci"},{"issue":"2","key":"9975_CR170","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.pcl.2018.12.009","volume":"66","author":"K Kesavan","year":"2019","unstructured":"Kesavan K, Devaskar SU. Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes. Pediatr Clin North Am. 2019;66(2):403\u201323. https:\/\/doi.org\/10.1016\/j.pcl.2018.12.009.","journal-title":"Pediatr Clin North Am"},{"key":"9975_CR171","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4137\/CMPed.S40070","volume":"10","author":"D Sharma","year":"2016","unstructured":"Sharma D, Shastri S, Sharma P. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clin Med Insights Pediatr. 2016;10:67\u201383. https:\/\/doi.org\/10.4137\/CMPed.S40070.","journal-title":"Clin Med Insights Pediatr"},{"issue":"2","key":"9975_CR172","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0034-1376179","volume":"32","author":"N Hassan","year":"2015","unstructured":"Hassan N, Patenaude V, Oddy L, Abenhaim HA. Pregnancy outcomes in Marfan syndrome: a retrospective cohort study. Am J Perinatol. 2015;32(2):123\u201330. https:\/\/doi.org\/10.1055\/s-0034-1376179.","journal-title":"Am J Perinatol"},{"key":"9975_CR173","doi-asserted-by":"publisher","unstructured":"K. M. Summers, S. J. Bush, M. R. Davis, D. A. Hume, S. Keshvari, and J. A. West, \u201cFibrillin-1 and asprosin, novel players in metabolic syndrome.,\u201d Mol. Genet. Metab., vol. 138, no. 1, p. 106979, Jan. 2023. https:\/\/doi.org\/10.1016\/j.ymgme.2022.106979.","DOI":"10.1016\/j.ymgme.2022.106979"},{"issue":"2","key":"9975_CR174","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12079-020-00566-3","volume":"14","author":"ML Muthu","year":"2020","unstructured":"Muthu ML, Reinhardt DP. Fibrillin-1 and fibrillin-1-derived asprosin in adipose tissue function and metabolic disorders. J Cell Commun Signal. 2020;14(2):159\u201373. https:\/\/doi.org\/10.1007\/s12079-020-00566-3.","journal-title":"J Cell Commun Signal"},{"issue":"1\u20132","key":"9975_CR175","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ymgme.2016.06.009","volume":"119","author":"MR Davis","year":"2016","unstructured":"Davis MR, et al. Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions. Mol Genet Metab. 2016;119(1\u20132):174\u201385. https:\/\/doi.org\/10.1016\/j.ymgme.2016.06.009.","journal-title":"Mol Genet Metab"},{"key":"9975_CR176","doi-asserted-by":"publisher","unstructured":"P. V R\u00f6der, B. Wu, Y. Liu, and W. Han, \u201cPancreatic regulation of glucose homeostasis.,\u201d Exp. Mol. Med., vol. 48, no. 3, p. e219, Mar. 2016. https:\/\/doi.org\/10.1038\/emm.2016.6.","DOI":"10.1038\/emm.2016.6"},{"issue":"3","key":"9975_CR177","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000096582","volume":"67","author":"P Ghirri","year":"2007","unstructured":"Ghirri P, et al. Low birth weight for gestational age associates with reduced glucose concentrations at birth, infancy and childhood. Horm Res. 2007;67(3):123\u201331. https:\/\/doi.org\/10.1159\/000096582.","journal-title":"Horm Res"},{"issue":"6","key":"9975_CR178","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jdi.12094","volume":"4","author":"M Komatsu","year":"2013","unstructured":"Komatsu M, Takei M, Ishii H, Sato Y. Glucose-stimulated insulin secretion: A newer perspective. J Diabetes Investig. 2013;4(6):511\u20136. https:\/\/doi.org\/10.1111\/jdi.12094.","journal-title":"J Diabetes Investig"},{"issue":"2","key":"9975_CR179","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1900\/RDS.2004.1.58","volume":"1","author":"C Geremia","year":"2004","unstructured":"Geremia C, Cianfarani S. Insulin sensitivity in children born small for gestational age (SGA). Rev Diabet Stud. 2004;1(2):58\u201365. https:\/\/doi.org\/10.1900\/RDS.2004.1.58.","journal-title":"Rev Diabet Stud"},{"issue":"7121","key":"9975_CR180","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"J-P Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881\u20137. https:\/\/doi.org\/10.1038\/nature05488.","journal-title":"Nature"},{"key":"9975_CR181","doi-asserted-by":"publisher","first-page":"1288326","DOI":"10.3389\/fendo.2024.1288326","volume":"15","author":"R Lei","year":"2024","unstructured":"Lei R, Chen S, Li W. Advances in the study of the correlation between insulin resistance and infertility. Front Endocrinol (Lausanne). 2024;15:1288326. https:\/\/doi.org\/10.3389\/fendo.2024.1288326.","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"9975_CR182","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5152\/jtgga.2015.15232","volume":"16","author":"Z\u00d6 Da\u011f","year":"2015","unstructured":"Da\u011f Z\u00d6, Dilbaz B. Impact of obesity on infertility in women. J Turkish Ger Gynecol Assoc. 2015;16(2):111\u20137. https:\/\/doi.org\/10.5152\/jtgga.2015.15232.","journal-title":"J Turkish Ger Gynecol Assoc"},{"issue":"11","key":"9975_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18112435","volume":"18","author":"M Ciebiera","year":"2017","unstructured":"Ciebiera M, et al. Role of transforming growth factor \u03b2 in uterine fibroid biology. Int J Mol Sci. 2017;18(11):1\u201316. https:\/\/doi.org\/10.3390\/ijms18112435.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"9975_CR184","doi-asserted-by":"publisher","first-page":"e1434","DOI":"10.1002\/hsr2.1434","volume":"6","author":"M Mahdizadehi","year":"2023","unstructured":"Mahdizadehi M, Saghaeian Jazi M, Mir SM, Jafari SM. Role of fibrilins in human cancer: A narrative review. Heal Sci reports. 2023;6(7):e1434. https:\/\/doi.org\/10.1002\/hsr2.1434.","journal-title":"Heal. Sci. reports"},{"key":"9975_CR185","doi-asserted-by":"publisher","unstructured":"J. R. Ko et al., \u201cAerobic Exercise Training Decreases Hepatic Asprosin in Diabetic Rats.,\u201d J. Clin. Med., vol. 8, no. 5, May 2019. https:\/\/doi.org\/10.3390\/jcm8050666.","DOI":"10.3390\/jcm8050666"},{"issue":"1","key":"9975_CR186","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1933719113485294","volume":"21","author":"N Raja-Khan","year":"2014","unstructured":"Raja-Khan N, Urbanek M, Rodgers RJ, Legro RS. The role of TGF-\u03b2 in polycystic ovary syndrome. Reprod Sci. 2014;21(1):20\u201331. https:\/\/doi.org\/10.1177\/1933719113485294.","journal-title":"Reprod Sci"},{"key":"9975_CR187","doi-asserted-by":"publisher","unstructured":"P. K. Zakrzewski, \u201cCanonical TGF\u03b2 Signaling and Its Contribution to Endometrial Cancer Development and Progression-Underestimated Target of Anticancer Strategies.,\u201d J. Clin. Med., vol. 10, no. 17, Aug. 2021. https:\/\/doi.org\/10.3390\/jcm10173900.","DOI":"10.3390\/jcm10173900"},{"issue":"3","key":"9975_CR188","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/s1472-6483(10)61828-7","volume":"5","author":"EE Nilsson","year":"2002","unstructured":"Nilsson EE, Skinner MK. Role of transforming growth factor beta in ovarian surface epithelium biology and ovarian cancer. Reprod Biomed Online. 2002;5(3):254\u20138. https:\/\/doi.org\/10.1016\/s1472-6483(10)61828-7.","journal-title":"Reprod Biomed Online"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-025-09975-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T09:35:33Z","timestamp":1749461733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-025-09975-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":188,"alternative-id":["9975"],"URL":"https:\/\/doi.org\/10.1007\/s11154-025-09975-4","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"31 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}